Aung 2021.
Study name | Community‐integrated intermediary care (CIIC) service model to enhance family‐based, long‐term care for older people: protocol for a cluster‐randomized controlled trial in Thailand |
Methods |
Study design: cluster‐RCT Country: Thailand |
Participants | Older adults (> 60 years) and their caregivers Inclusion criteria: a. > 60 years of age; b. has a family caregiver(s); c. either male or female; d. resident in study site districts. Exclusion criteria: a. lack of informed consent by those > 60 years old or their family caregivers; b. cannot understand the explanation for informed consent despite being provided with language support; c. in a household without an older person > 60 years old; d. cognitive impairment or severe impairment of decision‐making abilities. Stated purpose: to assess the effectiveness of a CIIC facility and its functions to assist families providing LTC for older adults in terms of reducing caregivers’ burden as the primary outcome. Another objective is to evaluate the effectiveness of the CIIC model in terms of the following secondary outcomes: impact on ADL, depression, and QOL of older people. |
Interventions |
Intervention: Care capacity building for family caregivers based on community‐integrated intermediary care (CIIC) service model Caregiving capacity building educational programme will be provided to the family caregivers of dependent older adults. Training delivered at home or can be group training, depending on the individual situation and specific care need. Control: Usual care (i.e. the current system of LTC common to all provinces in Thailand), consisting principally of a volunteer‐assisted home care service in addition to traditional family‐based home care. |
Outcomes |
Participants' outcomes of interest for this review
Economic outcomes Nil Time points: baseline, post‐intervention (6 months) |
Starting date | May 2019 |
Contact information | Myo Nyein Aung, dr.myonyeinaung@gmail.com |
Notes |
Source of funding: World Health Organization Centre for Health Development (WHO Kobe Centre – WKC: K18020) Prospective trial registration number: Thai Clinical Trials Registry TCTR20190412004 |